bryan johnson bpc-157 bpc 157 Join me on today's episode of The Doctor's Farmacy as Dr. Edwin Lee and I explore the transformative potential of peptides. We 🤨PEPTIDES🤨 Its incredibly difficult to

Its not about what the bottle says its about what the blood shows

Increased fatty-acid availability is not identical to increased oxidation

Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation

In laboratory settings, it is investigated for its role in actin dynamics and cell migration